Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2018 | Oct. 29, 2018 | |
Document Information [Line Items] | ||
Entity Registrant Name | Zero Gravity Solutions, Inc. | |
Entity Central Index Key | 1,574,186 | |
Trading Symbol | zgsi | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Current Reporting Status | Yes | |
Entity Emerging Growth Company | false | |
Entity Small Business | true | |
Entity Common Stock, Shares Outstanding (in shares) | 40,954,115 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2018 | |
Document Fiscal Year Focus | 2,018 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 |
CURRENT ASSETS | ||
Cash | $ 44,423 | $ 13,862 |
Accounts receivable, net | 563 | 1,393 |
Prepaid expenses | 167,288 | 216,139 |
Inventory | 68,193 | 68,643 |
Total current assets | 280,467 | 300,037 |
Property and equipment - net | 98,011 | 104,590 |
OTHER ASSETS | ||
Deposits | 4,817 | 4,617 |
Intellectual property | 11,086 | 11,458 |
Advance on future royalties - related parties, net | 319,441 | |
Total other assets | 15,903 | 335,516 |
TOTAL ASSETS | 394,381 | 740,143 |
CURRENT LIABILITIES | ||
Accounts payable and other payables | 659,139 | 693,695 |
Accounts payable, related party | 82,500 | 80,097 |
Accrued interest | 7,083 | 2,500 |
Accrued interest, related party | 50,544 | 32,250 |
Deferred compensation, related party | 12,500 | 12,500 |
Convertible Note payable - related party | 500,000 | 500,000 |
Note payable | 154,822 | 204,419 |
Total liabilities (all current) | 1,466,588 | 1,525,461 |
LONG TERM LIABILITIES | ||
Carrying value | 277,660 | 181,782 |
Notes payable, related parties, net of discount of $168,306 and $97,796 | 1,831,694 | 1,002,204 |
Total long-term liabilities | 2,109,354 | 1,183,986 |
Total Liabilities | 3,575,942 | 2,709,447 |
Commitments (Note 4) | ||
STOCKHOLDERS' DEFICIT | ||
Common stock; 100,000,000 shares authorized, at $0.001 par value, 40,705,731 and 40,650,397 shares issued and outstanding, at March 31, 2018 and December 31, 2017, respectively | 40,706 | 40,650 |
Additional paid-in capital | 22,334,630 | 21,970,266 |
Accumulated deficit | (25,556,897) | (23,980,220) |
Total stockholders' deficit | (3,181,561) | (1,969,304) |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ 394,381 | $ 740,143 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 |
Note payable, discount | $ 22,340 | $ 18,218 |
Notes payable, related parties, discount | $ 168,306 | $ 97,769 |
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares issued (in shares) | 40,705,731 | 40,650,397 |
Common stock, shares outstanding (in shares) | 40,705,731 | 40,650,397 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
REVENUE | ||
Revenues | $ 3,470 | $ 255 |
COST OF REVENUE | ||
Cost of Goods Sold | 377 | 21 |
Royalty Expense | 173 | 13 |
Total Cost of Revenue | 550 | 34 |
GROSS PROFIT | 2,920 | 221 |
OPERATING EXPENSES | ||
General and administrative | 1,409,696 | 2,705,198 |
Research and development | 84,817 | 76,381 |
Total operating expenses | 1,494,513 | 2,781,579 |
LOSS FROM OPERATIONS | (1,491,593) | (2,781,358) |
OTHER INCOME (EXPENSE) | ||
Interest expense | (61,099) | (13,946) |
Accretion of debt discount | (23,642) | |
Loss on disposal of asset | (343) | |
Total other income (expense) | (85,084) | (13,946) |
NET LOSS | $ (1,576,677) | $ (2,795,304) |
NET LOSS PER SHARE - BASIC AND DILUTED (in dollars per share) | $ (0.04) | $ (0.07) |
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED (in shares) | 40,671,851 | 40,042,764 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net loss | $ (1,576,677) | $ (2,795,304) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation expense | 6,235 | 6,107 |
Amortization expense | 372 | 138 |
Bad debt expense | 4,060 | |
Common stock issued for services | 150,000 | |
Warrants issued for services | 57,570 | 283,039 |
Stock options issued as compensation | 71,254 | 76,644 |
Loss on disposal of asset | 343 | |
Advance on future royalties - related parties reserve | 123,560 | |
Impairment expense | 203,208 | |
Amortization of debt discounts | 23,642 | |
Warrant modification expense | 926,885 | |
Changes in operating assets and liabilities: | ||
Accounts receivable, trade | (3,230) | 92,670 |
Prepaid expenses | 48,851 | 60,110 |
Advance on future royalties - related parties | (7,327) | (21,992) |
Inventory | 450 | (47,394) |
Deposit | (200) | (200) |
Accounts payable, related party | 2,403 | |
Accounts payable and other payables | (34,556) | (2,114) |
Accrued interest, related party | 18,294 | |
Accrued interest | 4,584 | |
Net cash used in operating activities | (1,057,164) | (1,271,411) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Payments of notes payable | (49,597) | (65,118) |
Payments of notes payable - related party | (100,000) | |
Proceeds from exercise of warrants – related party | 1,185,000 | |
Payment of offering costs - related party | (27,000) | (33,750) |
Proceeds of notes payable | 100,000 | |
Proceeds of notes payable – related party | 1,000,000 | |
Proceeds from sale of common stock | 166,002 | 688,500 |
Payment of offering costs | (1,680) | (53,400) |
Net cash provided by financing activities | 1,087,725 | 1,721,232 |
NET INCREASE IN CASH | 30,561 | 449,821 |
CASH AT BEGINNING OF PERIOD | 13,862 | 232,394 |
CASH AT END OF PERIOD | 44,423 | 682,215 |
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | ||
Income Taxes | ||
Interest | 61,099 | 13,946 |
Warrants Issued as Equity Direct Offering Costs [Member] | ||
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Warrants issued | 377 | 22,970 |
Warrants Issued as Debt Discount [Member] | ||
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Warrants issued | $ 71,274 |
Note 1 - Organization and Summa
Note 1 - Organization and Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2018 | |
Notes to Financial Statements | |
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] | NOTE 1 Nature of operations Zero Gravity Solutions, Inc. (the “Company”) is a biotechnology company focused on commercializing technology derived from and designed for spaceflight with significant applications on Earth. These technologies are focused on improving world agriculture by providing valuable solutions to challenges facing humanity including threats to world agriculture and the ability to feed the world’s rapidly growing population. The Company owns proprietary technology for its initial commercial product, BAM-FX™ that can boost the nutritional value and enhance the immune system of food crops without the use of Genetic Modification. The Company’s focus is the commercialization of BAM-FX™ in both domestic and international markets. The Company’s headquarters are located in Boca Raton Florida. The Company operates through two 2014. Going Concern and Management’s Plans The Company has a working capital deficiency as of March 31, 2018, March 31, 2018, $44,000, 1,186,000 1,577,000 1,057,000 twelve March 31, 2018 March 31, 2018, no not may March 31, 2018, $2,350,000 $745,000 7 not Management’s strategic plans include the following: ● Continuing to advance commercialization of the Company’s principal product, BAM-FX™ in both domestic and international markets; ● Pursuing additional capital raising opportunities; ● Continuing to explore and execute prospective partnering or distribution opportunities; and ● Identifying unique market opportunities that represent potential positive cash flow. Interim Financial Statements The interim unaudited condensed consolidated financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations for the three March 31, 2018 2017, three March 31, 2018 2017, March 31, 2018 not Certain information and disclosures normally included in the notes to the annual consolidated financial statements have been condensed or omitted from these interim consolidated financial statements. Accordingly, these interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Report on Form 10 December 31, 2017 August 13, 2018. December 31, 2017 Use of Estimates The preparation of the unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements. Actual results could differ from those estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the allowance for doubtful accounts and other receivables, inventory reserves and classifications, amortization period and recoverability of intangible assets, valuation of beneficial conversion features in convertible debt, valuation of loss contingencies, valuation of stock-based compensation and the valuation allowance on deferred tax assets. Segment Reporting The Company views its operations and manages its business as one 100% not Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of Zero Gravity Solutions, Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Cash and Cash Equivalents For the purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with an original maturity of three no March 31, 2018 2017. Inventory Inventory is valued on a lower of first first March 31, December 31, 2018 2017 Raw materials $ 23,562 $ 23,562 Finished product 44,631 45,081 Total Inventory $ 68,193 $ 68,643 Property and Equipment Property and equipment is stated at cost, less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed on a straight-line basis over estimated useful lives. Property and equipment is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not Impairment of Long Lived Assets The Company accounts for long-lived assets in accordance with the provisions of ASC 360 10 35 15 may not Concentration of Credit Risk The Company believes that its credit risk exposure is limited. The Company has never suffered a loss due to excess balances. Fair Value of Financial Instruments The Company accounts for financial instruments under Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic (ASC) 820, Fair Value Measurements 820 three Level 1 Level 2 1, not Level 3 Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may As the Company's common stock is not 820. The carrying amounts of the Company’s accounts receivable and accounts payable approximate fair value due to the relatively short period to maturity for these instruments. The carrying value of the Company’s notes payable approximates fair value due to their short period to maturity and their stated interest rates, combined with historic interest rate levels. Revenue recognition and accounts receivable We recognize revenues from the sale of agricultural biotechnology products to distributors and customers pursuant to the provisions of ASC 606, Revenues for agricultural chemical products are recognized when title to the products is transferred which may When amounts are billed to customers for shipping and handling fees they are included in net sales, and the related costs incurred by the company for the delivery of invoiced goods are classified as cost of goods sold in our Statements of Operations. The Company determined that no three 31, 2018 2017 At March 31, 2018, two 100% 85.8%, 14.2%, March 31, 2018, two 100% 75% 25% 0% At December 31, 2017, three 100% three 46.5%, 34.9% 18.6%, 31, 2017, one 22.8% The Company extends credit to customers generally without requiring collateral. The Company monitors its exposure for credit losses and maintains allowances for anticipated losses. The Company records an allowance for doubtful accounts when it is probable that the accounts receivable balance will not March 31, 2018 December 31, 2017 $0 $32,663, Cost of sales Cost of sales is comprised of material costs, invoiced shipping costs and royalty expense. Warrants The Company recognizes the cost of warrants issued with debt as debt discount in the consolidated financial statements which is recorded at the warrants relative fair value which is measured based on the grant date fair value of the award. The Company estimates the fair value of each warrant at the grant date by using the Black-Scholes option pricing model. Stock based compensation The Company recognizes the cost of employee services received in exchange for an award of equity instruments in the consolidated financial statements which is measured based on the grant date fair value of the award. Stock based compensation expense is recognized over the period during which an employee is required to provide service in exchange for the award (generally the vesting period). The Company estimates the fair value of each stock award at the grant date by using the Black-Scholes option pricing model. Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no 2018 2017. The Company also grants share-based compensation awards to non-employees for service provided to the Company. The Company measures and recognizes the fair value of such transactions based on the fair value of consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. Loss per Share Loss per share is calculated by dividing the Company’s net loss by the weighted average number of common shares outstanding during the period. Diluted earnings loss per share is calculated by dividing the Company’s net income (loss) by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity instruments. The effect of the inclusion of the dilutive shares would have resulted in a decrease in loss per share. Accordingly, the weighted average shares outstanding have not not 13,550,332, 14,044,842 March 31, 2018 December 31, 2017, Research and Development Research and development costs are charged to expense as incurred. Warranty Expense The Company's distribution agreements provide for a warranty on products sold. As sales under such distribution agreements have been nominal through 2018 2017, no 2018 2017. Income Taxes The Company accounts for income taxes under the asset and liability method, in which deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. A valuation allowance is required to the extent any deferred tax assets may not The Company does not March 31, 2018 December 31, 2017. March 31, 2018, not March 31, 2018 2017. Reclassifications Certain amounts in the December 31, 2017 March 31, 2018 no Recently Issued Accounting Pronouncements In May 2014, 606, not Dec. 15, 2017. 606 no 2018 January 1, 2018, In March 2016, No. 2016 02, Leases No. 2016 02 No. 2016 02 not 12 not December 15, 2018. not not In June 2018, No. 2018 07, 718 No 2018 07 718 718 December 15, 2018, no 606. January 1, 2019. In July 2017, No. 2017 11 Earnings Per Share (Topic 260 480 815 2017 11” no 2017 11 no 2017 11 260 470 20. 2017 11 December 15, 2018. 2017 11 1. first 2017 11 2. 250 10 45 5 45 10. |
Note 2 - Property and Equipment
Note 2 - Property and Equipment | 3 Months Ended |
Mar. 31, 2018 | |
Notes to Financial Statements | |
Property, Plant and Equipment Disclosure [Text Block] | NOTE 2 March 31, 2018 December 31, 2017 Computer equipment $ 14,418 $ 15,332 Equipment and furniture 133,940 133,940 Leasehold improvements 7,593 7,593 155,951 156,865 Accumulated Depreciation (57,940 ) (52,275 ) Property and Equipment - Net $ 98,011 $ 104,590 Depreciation expense for the period ended March 31, 2018 2017 $6,235 $6,107, |
Note 3 - Related Party Transact
Note 3 - Related Party Transactions | 3 Months Ended |
Mar. 31, 2018 | |
Notes to Financial Statements | |
Related Party Transactions Disclosure [Text Block] | NOTE 3 Convertible Note Payable In July 2015, $500,000 8.5% July 2016. 350,000 $3 $416,618 0%, 184.2%, 1.66% 5 $227,258 July 2016, July 2017, $1.25 400,000 not 2017, $42,500 $10,625 December 31, 2017. 2017, July 2018 and then extended again in 2018 to July 2019. three March 31, 2017 2018, $10,389 $10,625 Notes Payable Date of Note Face Value Debt Discount Debt Discount Accretion Carrying Value August 2017 $ 100,000 $ 10,434 $ 3,131 $ 92,695 September 2017 $ 500,000 $ 52,166 $ 15,148 $ 462,982 October 2017 $ 500,000 $ 50,229 $ 10,665 $ 460,436 January 2018 $ 100,000 $ 3,831 $ 3,831 $ - January 2018 $ 500,000 $ 50,590 $ 5,678 $ 455,088 March 2018 $ 200,000 $ 20,281 $ 555 $ 180,274 March 2018 $ 200,000 $ 20,279 $ 498 $ 180,219 $ 2,000,000 $ 203,980 $ 35,674 $ 1,831,694 In August 2017, $100,000. 10.0%, August 2019. five 10,000 $3.00 $10,435 March 31, 2018, $1,287, In September 2017, $500,000. 10.0%, September 2019. five 50,000 $3.00 $52,166 three March 31, 2018, $6,431, In October 2017, $500,000 50,000 ten 10% October 26, 2019. may five 50,000 $3.00 $50,229 three March 31, 2018, $6,193, In January 2018, $100,000. 10.0%, three March 31, 2018. five 5,000 $3.00 $3,831 March 31, 2018, $3,831, On or about January 17, 2018, $500,000 January 16, 2018, October 26, 2019, $500,000, January 18, 2018 50,000 ten 10% October 26, 2019. may one 30 6 5 $3.00 $35,590 $15,000 three March 31, 2018, $5,678, On or about March 8, 2018, $200,000 March 8, 2018 March 9, 2018 20,000 ten 10% March 7, 2020. may one 5 $3.00 $14,281 $6,000 three March 31, 2018, $555, On or about March 12, 2018, $200,000 March 12, 2018, March 12, 2018 20,000 no not ten 10% March 11, 2020. may one 5 $3.00 $14,279 $6,000 three March 31, 2018, $498, 30 $3.00 June 30, 2018. 5 $3.00 Royalty Agreement In 2013, 2015, 25 5% $2,500 Sales subject to the royalty agreement were $3,470 $255 March 31, 2018 2017, March 31, 2018, December 31, 2017, $0 $319,441 $123,560 three 31, 2018. Included in advance of future royalties was $203,208 three March 31, 2018, Consulting Agreement In March 2015, six $200,000 $200,000 2015 $75,000 March 31, 2018 December 31, 2017. |
Note 4 - Commitments
Note 4 - Commitments | 3 Months Ended |
Mar. 31, 2018 | |
Notes to Financial Statements | |
Commitments Disclosure [Text Block] | NOTE 4 Lease Commitments The Company leases its office, building and laboratory space under short term leases. These leases are renewable either monthly or annually. The Company also has a two September 1, 2016 August 31, 2018. $54,325 $6,942 March 31, 2018 2017, License and Business Development Agreement On February 20, 2018, February 13, 2018 ( twenty 20% $500,000 no $500,000 pro rata March 31, 2018 not not The Agreement provides Agro Space with the exclusive right to import, package, sell and distribute BAM’s product lines and promote its brand, as well as other “white label” brands as they are introduced, in the Mexican markets, and a limited manufacturing right to modify the presentation of BAM’s products and dilute such products, all during the term of the Agreement. BAM will retain the right to all of its intellectual property, including any materials produced in connection with the Agreement and BAM’s products, and Agro Space will have a royalty-free right to reproduce, translate, summarize or otherwise use such materials for the sole purpose of performing pursuant to the Agreement. The exclusivity of the rights licensed to Agro Space are conditioned upon (i) Agro Space meeting specified revenue targets beginning on the third tenth five 5 In addition to BAM receiving an ownership interest in Agro Space, Zero Gravity Solutions, Inc. ("Company") received $100,000 2016 $3.00 $900,000, Research Commitment In January 2016, $373,750 2016, first five March 31, 2018 2017, $0 $29,610 |
Note 5 - Note Payable
Note 5 - Note Payable | 3 Months Ended |
Mar. 31, 2018 | |
Notes to Financial Statements | |
Debt Disclosure [Text Block] | NOTE 5 The Company has an outstanding note payable for financing corporate insurance premiums. The original principle value was $223,707. 7.5% November 2018 eleven $19,353. March 31, 2018 $154,822. Date of Note Face Value Debt Discount Debt Discount Accretion Carrying Value December 2017 $ 200,000 $ 18,652 $ 2,733 $ 184,081 January 2018 $ 100,000 $ 7,124 $ 703 $ 93,579 $ 300,000 $ 25,776 $ 3,436 $ 277,660 In December 2017, $200,000 December 14, 2017, December 13, 2019 $200,000, December 18, 2017 50,000 ten 10% may one 5 $3.00 $18,652 March 31, 2018, $2,300, On or about January 18, 2018, $100,000 January 19, 2018, January 18, 2020 $100,000, January 19, 2018 10,000 ten 10% may one 5 $3.00 $7,124 March 31, 2018, $703, |
Note 6 - Equity
Note 6 - Equity | 3 Months Ended |
Mar. 31, 2018 | |
Notes to Financial Statements | |
Shareholders' Equity and Share-based Payments [Text Block] | NOTE 6 2018 transactions: Common Stock Private placement offerings During 2016, $10,000,000 $3.00 2016 55,334 March 31, 2018. $166,002, $1,680. 490 $3.00 $377 Warrants Warrants issued for services During the period ended March 31, 2018, five 75 ,000 $3.00 $57,570, Warrants issued with debt In connection with the issuance of a $100,000 January 18, 2018, January 19, 2018 10,000 5 $3.00 $7,124 Warrants issued with debt – related party In January 2018, $100,000, five 5,000 $3.00 $3,831 In January 2018, five 50,000 $3.00 $500,000 $35,590 In March 2018, $200,000 five 20,000 $3.00 $14,281 In March 2018, $200,000 five 20,000 $3.00 $14,279 The following is a summary of the Company’s warrant activity for the year ended March 31, 2018: Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual (in Years) Aggregate Value Outstanding - January 1, 2017 9,664,733 $ 1.53 Granted 1,838,442 2.01 Exercised (790,000 ) 2.00 Cancelled/Forfeited - - Outstanding and exercisable - December 31, 2017 10,713,175 $ 1.86 2.8 $ 2,606,698 Outstanding - January 1, 2018 10,713,175 $ 1.86 Granted 180,490 3.00 Exercised - - Cancelled/Forfeited - - Outstanding and exercisable - March 31, 2018 10,893,665 $ 1.88 2.6 $ 2,861,010 The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the estimated fair value of the Company’s stock price on March 31, 2018 March 31, 2018. Stock incentive plan options In November 2015, 2015 4,000,000 three March 31, 2018 25,000 $1.25 10 $19,208 three March 31, 2108 March 31, 2018, $0, 101.7% 2.58%, 5 The Company recognizes compensation expense for stock option grants based on the fair value at the date of grant using the Black-Scholes option pricing model. As the Company does not zero $1.21 March 31, 2018 . The Company has elected to account for forfeitures as they occur. Number of Options Weighted Average Exercise Price Weighted (in Years) Aggregate Value Outstanding - January 1, 2017 2,755,000 $ 1.25 Granted 440,000 3.00 Exercised - - Cancelled/Forfeited (30,000 ) (1.25 ) Outstanding - December 31, 2017 3,165,000 $ 1.49 8.5 $ 192,850 Exercisable - December 31, 2017 2,750,000 $ 1.27 8.2 $ 192,850 Outstanding - January 1, 2018 3,165,000 $ 1.25 Granted 25,000 3.00 Exercised - - Cancelled/Forfeited (700,000 ) (1.25 ) Outstanding - March 31, 2018 2,490,000 $ 1.58 8.4 $ - Exercisable - March 31, 2018 2,072,500 $ 1.33 8.2 $ - The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the estimated fair value of the Company’s stock price on March 31, 2018 March 31, 2018. |
Note 7 - Subsequent Events
Note 7 - Subsequent Events | 3 Months Ended |
Mar. 31, 2018 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | NOTE 7 – SUBSEQUENT EVENTS On May 2, 2018, $300,001 May 2, 2018, May 2, 2018 30,000 ten 10% May 1, 2020. may one On April 24, 2018 $200,000 3 Effective on June 28, 2018, $10,000,000 3,333,333 $3.00 October 2016. March 31, 2018, 248,384 2016 $745,151, $24,000, 7,000 On June 29, 2018, “June 2018 $2,000,000 10% “June 2018 two 2,000,000 $1.00 “June 2018 July 31, 2018, one On June 29, 2018, $1,000,000 June 2018 June 2018 June 28, 2020, June 2018 second $250,000 July 2, 2018 $250,000 July 17, 2018, June 2018 July 2, 2020 July 17, 2020, June 2018 $550,000 seven June 2018 June 2018 June 2018 June 2018 $2,050,000, June 2018 2,050,000 Subsequent to March 31, 2018, five 165,000 $3.00 |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2018 | |
Accounting Policies [Abstract] | |
Going Concern and Management Plans [Policy Text Block] | Going Concern and Management’s Plans The Company has a working capital deficiency as of March 31, 2018, March 31, 2018, $44,000, 1,186,000 1,577,000 1,057,000 twelve March 31, 2018 March 31, 2018, no not may March 31, 2018, $2,350,000 $745,000 7 not Management’s strategic plans include the following: ● Continuing to advance commercialization of the Company’s principal product, BAM-FX™ in both domestic and international markets; ● Pursuing additional capital raising opportunities; ● Continuing to explore and execute prospective partnering or distribution opportunities; and ● Identifying unique market opportunities that represent potential positive cash flow. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates The preparation of the unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements. Actual results could differ from those estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the allowance for doubtful accounts and other receivables, inventory reserves and classifications, amortization period and recoverability of intangible assets, valuation of beneficial conversion features in convertible debt, valuation of loss contingencies, valuation of stock-based compensation and the valuation allowance on deferred tax assets. |
Segment Reporting, Policy [Policy Text Block] | Segment Reporting The Company views its operations and manages its business as one 100% not |
Consolidation, Policy [Policy Text Block] | Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of Zero Gravity Solutions, Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents For the purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with an original maturity of three no March 31, 2018 2017. |
Inventory, Policy [Policy Text Block] | Inventory Inventory is valued on a lower of first first March 31, December 31, 2018 2017 Raw materials $ 23,562 $ 23,562 Finished product 44,631 45,081 Total Inventory $ 68,193 $ 68,643 |
Property, Plant and Equipment, Policy [Policy Text Block] | Property and Equipment Property and equipment is stated at cost, less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed on a straight-line basis over estimated useful lives. Property and equipment is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not |
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] | Impairment of Long Lived Assets The Company accounts for long-lived assets in accordance with the provisions of ASC 360 10 35 15 may not |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | Concentration of Credit Risk The Company believes that its credit risk exposure is limited. The Company has never suffered a loss due to excess balances. |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value of Financial Instruments The Company accounts for financial instruments under Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic (ASC) 820, Fair Value Measurements 820 three Level 1 Level 2 1, not Level 3 Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may As the Company's common stock is not 820. The carrying amounts of the Company’s accounts receivable and accounts payable approximate fair value due to the relatively short period to maturity for these instruments. The carrying value of the Company’s notes payable approximates fair value due to their short period to maturity and their stated interest rates, combined with historic interest rate levels. |
Revenue Recognition and Accounts Receivable [Policy Text Block] | Revenue recognition and accounts receivable We recognize revenues from the sale of agricultural biotechnology products to distributors and customers pursuant to the provisions of ASC 606, Revenues for agricultural chemical products are recognized when title to the products is transferred which may When amounts are billed to customers for shipping and handling fees they are included in net sales, and the related costs incurred by the company for the delivery of invoiced goods are classified as cost of goods sold in our Statements of Operations. The Company determined that no three 31, 2018 2017 At March 31, 2018, two 100% 85.8%, 14.2%, March 31, 2018, two 100% 75% 25% 0% At December 31, 2017, three 100% three 46.5%, 34.9% 18.6%, 31, 2017, one 22.8% The Company extends credit to customers generally without requiring collateral. The Company monitors its exposure for credit losses and maintains allowances for anticipated losses. The Company records an allowance for doubtful accounts when it is probable that the accounts receivable balance will not March 31, 2018 December 31, 2017 $0 $32,663, |
Cost of Sales, Policy [Policy Text Block] | Cost of sales Cost of sales is comprised of material costs, invoiced shipping costs and royalty expense. |
Warrants [Policy Text Block] | Warrants The Company recognizes the cost of warrants issued with debt as debt discount in the consolidated financial statements which is recorded at the warrants relative fair value which is measured based on the grant date fair value of the award. The Company estimates the fair value of each warrant at the grant date by using the Black-Scholes option pricing model. |
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] | Stock based compensation The Company recognizes the cost of employee services received in exchange for an award of equity instruments in the consolidated financial statements which is measured based on the grant date fair value of the award. Stock based compensation expense is recognized over the period during which an employee is required to provide service in exchange for the award (generally the vesting period). The Company estimates the fair value of each stock award at the grant date by using the Black-Scholes option pricing model. Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no 2018 2017. The Company also grants share-based compensation awards to non-employees for service provided to the Company. The Company measures and recognizes the fair value of such transactions based on the fair value of consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. |
Earnings Per Share, Policy [Policy Text Block] | Loss per Share Loss per share is calculated by dividing the Company’s net loss by the weighted average number of common shares outstanding during the period. Diluted earnings loss per share is calculated by dividing the Company’s net income (loss) by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity instruments. The effect of the inclusion of the dilutive shares would have resulted in a decrease in loss per share. Accordingly, the weighted average shares outstanding have not not 13,550,332, 14,044,842 March 31, 2018 December 31, 2017, |
Research and Development Expense, Policy [Policy Text Block] | Research and Development Research and development costs are charged to expense as incurred. |
Standard Product Warranty, Policy [Policy Text Block] | Warranty Expense The Company's distribution agreements provide for a warranty on products sold. As sales under such distribution agreements have been nominal through 2018 2017, no 2018 2017. |
Income Tax, Policy [Policy Text Block] | Income Taxes The Company accounts for income taxes under the asset and liability method, in which deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. A valuation allowance is required to the extent any deferred tax assets may not The Company does not March 31, 2018 December 31, 2017. March 31, 2018, not March 31, 2018 2017. |
Reclassification, Policy [Policy Text Block] | Reclassifications Certain amounts in the December 31, 2017 March 31, 2018 no |
New Accounting Pronouncements, Policy [Policy Text Block] | Recently Issued Accounting Pronouncements In May 2014, 606, not Dec. 15, 2017. 606 no 2018 January 1, 2018, In March 2016, No. 2016 02, Leases No. 2016 02 No. 2016 02 not 12 not December 15, 2018. not not In June 2018, No. 2018 07, 718 No 2018 07 718 718 December 15, 2018, no 606. January 1, 2019. In July 2017, No. 2017 11 Earnings Per Share (Topic 260 480 815 2017 11” no 2017 11 no 2017 11 260 470 20. 2017 11 December 15, 2018. 2017 11 1. first 2017 11 2. 250 10 45 5 45 10. |
Note 1 - Organization and Sum_2
Note 1 - Organization and Summary of Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Notes Tables | |
Schedule of Inventory, Current [Table Text Block] | March 31, December 31, 2018 2017 Raw materials $ 23,562 $ 23,562 Finished product 44,631 45,081 Total Inventory $ 68,193 $ 68,643 |
Note 2 - Property and Equipme_2
Note 2 - Property and Equipment (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Notes Tables | |
Property, Plant and Equipment [Table Text Block] | March 31, 2018 December 31, 2017 Computer equipment $ 14,418 $ 15,332 Equipment and furniture 133,940 133,940 Leasehold improvements 7,593 7,593 155,951 156,865 Accumulated Depreciation (57,940 ) (52,275 ) Property and Equipment - Net $ 98,011 $ 104,590 |
Note 3 - Related Party Transa_2
Note 3 - Related Party Transactions (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Notes Tables | |
Schedule of Related Party Transactions [Table Text Block] | Notes Payable Date of Note Face Value Debt Discount Debt Discount Accretion Carrying Value August 2017 $ 100,000 $ 10,434 $ 3,131 $ 92,695 September 2017 $ 500,000 $ 52,166 $ 15,148 $ 462,982 October 2017 $ 500,000 $ 50,229 $ 10,665 $ 460,436 January 2018 $ 100,000 $ 3,831 $ 3,831 $ - January 2018 $ 500,000 $ 50,590 $ 5,678 $ 455,088 March 2018 $ 200,000 $ 20,281 $ 555 $ 180,274 March 2018 $ 200,000 $ 20,279 $ 498 $ 180,219 $ 2,000,000 $ 203,980 $ 35,674 $ 1,831,694 |
Note 5 - Note Payable (Tables)
Note 5 - Note Payable (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Notes Tables | |
Schedule of Debt [Table Text Block] | Date of Note Face Value Debt Discount Debt Discount Accretion Carrying Value December 2017 $ 200,000 $ 18,652 $ 2,733 $ 184,081 January 2018 $ 100,000 $ 7,124 $ 703 $ 93,579 $ 300,000 $ 25,776 $ 3,436 $ 277,660 |
Note 6 - Equity (Tables)
Note 6 - Equity (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Notes Tables | |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual (in Years) Aggregate Value Outstanding - January 1, 2017 9,664,733 $ 1.53 Granted 1,838,442 2.01 Exercised (790,000 ) 2.00 Cancelled/Forfeited - - Outstanding and exercisable - December 31, 2017 10,713,175 $ 1.86 2.8 $ 2,606,698 Outstanding - January 1, 2018 10,713,175 $ 1.86 Granted 180,490 3.00 Exercised - - Cancelled/Forfeited - - Outstanding and exercisable - March 31, 2018 10,893,665 $ 1.88 2.6 $ 2,861,010 |
Share-based Compensation, Stock Options, Activity [Table Text Block] | Number of Options Weighted Average Exercise Price Weighted (in Years) Aggregate Value Outstanding - January 1, 2017 2,755,000 $ 1.25 Granted 440,000 3.00 Exercised - - Cancelled/Forfeited (30,000 ) (1.25 ) Outstanding - December 31, 2017 3,165,000 $ 1.49 8.5 $ 192,850 Exercisable - December 31, 2017 2,750,000 $ 1.27 8.2 $ 192,850 Outstanding - January 1, 2018 3,165,000 $ 1.25 Granted 25,000 3.00 Exercised - - Cancelled/Forfeited (700,000 ) (1.25 ) Outstanding - March 31, 2018 2,490,000 $ 1.58 8.4 $ - Exercisable - March 31, 2018 2,072,500 $ 1.33 8.2 $ - |
Note 1 - Organization and Sum_3
Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual) - USD ($) | 3 Months Ended | 7 Months Ended | 12 Months Ended | ||
Mar. 31, 2018 | Mar. 31, 2017 | Oct. 22, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Number of Wholly Owned Subsidiaries | 2 | ||||
Cash, Ending Balance | $ 44,423 | $ 682,215 | $ 13,862 | $ 232,394 | |
Working Capital | (1,186,000) | ||||
Net Income (Loss) Attributable to Parent, Total | (1,576,677) | (2,795,304) | |||
Net Cash Provided by (Used in) Operating Activities, Total | (1,057,164) | (1,271,411) | |||
Proceeds from Issuance of Common Stock | $ 166,002 | 688,500 | |||
Number of Reportable Segments | 1 | ||||
Cash Equivalents, at Carrying Value, Total | $ 0 | 0 | |||
Impairment of Long-Lived Assets Held-for-use | 0 | 0 | |||
Allowance for Doubtful Accounts Receivable, Current, Ending Balance | $ 0 | $ 32,663 | |||
Weighted Average Number Diluted Shares Outstanding Adjustment, Total | 13,550,332 | 14,044,842 | |||
Product Warranty Expense | $ 0 | $ 0 | |||
Unrecognized Tax Benefits, Interest on Income Taxes Expense | 0 | $ 0 | |||
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total | $ 0 | $ 0 | |||
Geographic Concentration Risk [Member] | Sales Revenue, Net [Member] | UNITED STATES | |||||
Concentration Risk, Percentage | 100.00% | ||||
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | |||||
Number of Major Customers | 2 | 1 | |||
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Customer One [Member] | |||||
Concentration Risk, Percentage | 75.00% | ||||
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Customer Two [Member] | |||||
Concentration Risk, Percentage | 25.00% | ||||
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Two Customers [Member] | |||||
Concentration Risk, Percentage | 100.00% | ||||
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | One Customer [Member] | |||||
Concentration Risk, Percentage | 22.80% | ||||
Customer Concentration Risk [Member] | Accounts Receivable [Member] | |||||
Concentration Risk, Percentage | 100.00% | ||||
Number of Major Customers | 2 | 3 | |||
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member] | |||||
Concentration Risk, Percentage | 85.80% | 46.50% | |||
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member] | |||||
Concentration Risk, Percentage | 14.20% | 34.90% | |||
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Three Customers [Member] | |||||
Concentration Risk, Percentage | 100.00% | ||||
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member] | |||||
Concentration Risk, Percentage | 18.60% | ||||
Subsequent Event [Member] | |||||
Proceeds from Issuance of Long-term Debt, Total | $ 2,350,000 | ||||
Proceeds from Issuance of Common Stock | $ 745,000 |
Note 1 - Organization and Sum_4
Note 1 - Organization and Summary of Significant Accounting Policies - Summary of Inventory (Details) - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 |
Raw materials | $ 23,562 | $ 23,562 |
Finished product | 44,631 | 45,081 |
Total Inventory | $ 68,193 | $ 68,643 |
Note 2 - Property and Equipme_3
Note 2 - Property and Equipment (Details Textual) - USD ($) | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Depreciation, Total | $ 6,235 | $ 6,107 |
Note 2 - Property and Equipme_4
Note 2 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 |
Property and Equipment, Gross | $ 155,951 | $ 156,865 |
Accumulated Depreciation | (57,940) | (52,275) |
Property and Equipment - Net | 98,011 | 104,590 |
Computer Equipment [Member] | ||
Property and Equipment, Gross | 14,418 | 15,332 |
Equipment and Furniture [Member] | ||
Property and Equipment, Gross | 133,940 | 133,940 |
Leasehold Improvements [Member] | ||
Property and Equipment, Gross | $ 7,593 | $ 7,593 |
Note 3 - Related Party Transa_3
Note 3 - Related Party Transactions (Details Textual) | Mar. 12, 2018USD ($)$ / sharesshares | Mar. 08, 2018USD ($)$ / shares | Jan. 17, 2018USD ($) | Oct. 31, 2017USD ($)$ / sharesshares | Sep. 30, 2017USD ($)$ / sharesshares | Aug. 31, 2017USD ($)$ / sharesshares | Jul. 31, 2016$ / shares | Jul. 31, 2015USD ($)$ / sharesshares | Mar. 31, 2015USD ($) | Mar. 31, 2018USD ($)$ / sharesshares | Mar. 31, 2017USD ($) | Dec. 31, 2017USD ($)$ / shares | Dec. 31, 2015USD ($) | Mar. 09, 2018$ / sharesshares | Jan. 31, 2018USD ($)$ / sharesshares | Jan. 18, 2018$ / sharesshares | Dec. 14, 2017USD ($) | Dec. 31, 2016USD ($)$ / shares |
Proceeds from Related Party Debt | $ 1,000,000 | |||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.88 | $ 1.86 | $ 1.53 | |||||||||||||||
Accounts Payable, Related Parties, Current | $ 82,500 | $ 80,097 | ||||||||||||||||
Accretion Expense | 23,642 | |||||||||||||||||
Prepaid Royalties, Related Party, Noncurrent | 319,441 | |||||||||||||||||
General and Administrative Expense, Total | 1,409,696 | 2,705,198 | ||||||||||||||||
Unsecured Promissory Note [Member] | ||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||
Debt Instrument, Unamortized Discount, Total | 18,652 | |||||||||||||||||
Debt Instrument, Face Amount | $ 200,000 | |||||||||||||||||
First Warrant [Member] | ||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | $ 3 | ||||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | 5 years | ||||||||||||||||
Director [Member] | ||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 50,000 | |||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | |||||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | |||||||||||||||||
Director [Member] | Promissory Note [Member] | ||||||||||||||||||
Proceeds from Related Party Debt | $ 500,000 | |||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||
Debt Instrument, Unamortized Discount, Total | $ 52,166 | |||||||||||||||||
Accretion Expense | 6,431 | |||||||||||||||||
Director [Member] | Unsecured Promissory Note [Member] | Third Note [Member] | ||||||||||||||||||
Proceeds from Related Party Debt | $ 200,000 | |||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||
Debt Instrument, Unamortized Discount, Total | $ 14,281 | 14,281 | ||||||||||||||||
Accretion Expense | 555 | |||||||||||||||||
Debt Instrument, Face Amount | $ 200,000 | |||||||||||||||||
Debt Instrument, Fee Amount | $ 6,000 | |||||||||||||||||
Director [Member] | Warrants Issued with Debt [Member] | Measurement Input, Expected Dividend Rate [Member] | ||||||||||||||||||
Warrants and Rights Outstanding, Measurement Input | 0 | |||||||||||||||||
Director [Member] | Warrants Issued with Debt [Member] | Measurement Input, Price Volatility [Member] | ||||||||||||||||||
Warrants and Rights Outstanding, Measurement Input | 1.842 | |||||||||||||||||
Director [Member] | Warrants Issued with Debt [Member] | Measurement Input, Risk Free Interest Rate [Member] | ||||||||||||||||||
Warrants and Rights Outstanding, Measurement Input | 0.0166 | |||||||||||||||||
Director [Member] | Warrants Issued with Debt [Member] | Measurement Input, Expected Term [Member] | ||||||||||||||||||
Warrants and Rights Outstanding, Measurement Input | 5 | |||||||||||||||||
Director [Member] | Third Warrant [Member] | ||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 20,000 | 20,000 | ||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | $ 3 | $ 3 | |||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | 5 years | 5 years | |||||||||||||||
Director [Member] | Notes Payable [Member] | ||||||||||||||||||
Proceeds from Related Party Debt | $ 500,000 | |||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.50% | |||||||||||||||||
Debt Instrument, Unamortized Discount, Total | $ 227,258 | |||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 1.25 | |||||||||||||||||
Debt Instrument, Convertible, Number of Equity Instruments | 400,000 | |||||||||||||||||
Interest Expense, Related Party | $ 10,625 | 10,389 | 42,500 | |||||||||||||||
Accounts Payable, Related Parties, Current | 10,625 | |||||||||||||||||
Director [Member] | Notes Payable [Member] | Warrants Issued with Debt [Member] | ||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 350,000 | |||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | |||||||||||||||||
Warrants and Rights Outstanding | $ 416,618 | |||||||||||||||||
Director [Member] | Consulting Agreement [Member] | ||||||||||||||||||
Accounts Payable, Related Parties, Current | $ 75,000 | $ 75,000 | ||||||||||||||||
Related Party Transaction, Amounts of Transaction | $ 200,000 | |||||||||||||||||
General and Administrative Expense, Total | $ 200,000 | |||||||||||||||||
Employee [Member] | ||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 10,000 | |||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | |||||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | |||||||||||||||||
Employee [Member] | Promissory Note [Member] | ||||||||||||||||||
Proceeds from Related Party Debt | $ 100,000 | |||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||
Debt Instrument, Unamortized Discount, Total | $ 10,435 | |||||||||||||||||
Accretion Expense | 1,287 | |||||||||||||||||
Rio Vista [Member] | Unsecured Promissory Note [Member] | ||||||||||||||||||
Proceeds from Related Party Debt | $ 500,000 | |||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||
Debt Instrument, Unamortized Discount, Total | $ 50,229 | $ 35,590 | ||||||||||||||||
Accretion Expense | 6,193 | |||||||||||||||||
Debt Instrument, Face Amount | $ 500,000 | |||||||||||||||||
Rio Vista [Member] | Warrants Issued to Rio Vista [Member] | ||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 50,000 | 50,000 | ||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | $ 3 | ||||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | 5 years | ||||||||||||||||
Investor [Member] | Unsecured Promissory Note [Member] | First Note [Member] | ||||||||||||||||||
Proceeds from Related Party Debt | $ 500,000 | |||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | 10.00% | ||||||||||||||||
Debt Instrument, Unamortized Discount, Total | $ 3,831 | |||||||||||||||||
Accretion Expense | 3,831 | |||||||||||||||||
Debt Instrument, Face Amount | $ 500,000 | $ 100,000 | ||||||||||||||||
Investor [Member] | Unsecured Promissory Note [Member] | Second Note [Member] | ||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||
Debt Instrument, Unamortized Discount, Total | 35,590 | |||||||||||||||||
Accretion Expense | 5,678 | |||||||||||||||||
Debt Instrument, Fee Amount | $ 15,000 | |||||||||||||||||
Investor [Member] | First Warrant [Member] | ||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 5,000 | 50,000 | ||||||||||||||||
BPI [Member] | Unsecured Promissory Note [Member] | Third Note [Member] | ||||||||||||||||||
Proceeds from Related Party Debt | $ 200,000 | |||||||||||||||||
BPI [Member] | Unsecured Promissory Note [Member] | Fourth Note [Member] | ||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | |||||||||||||||||
Debt Instrument, Unamortized Discount, Total | 14,279 | |||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 3 | |||||||||||||||||
Accretion Expense | 498 | |||||||||||||||||
Debt Instrument, Face Amount | 200,000 | |||||||||||||||||
Debt Instrument, Fee Amount | $ 6,000 | |||||||||||||||||
BPI [Member] | Fourth Warrant [Member] | ||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 20,000 | 20,000 | ||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | $ 3 | ||||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | 5 years | ||||||||||||||||
Key Employee and Principal Stockholder and Current Director [Member] | Royalty Agreement [Member] | ||||||||||||||||||
Deferred Compensation Arrangement with Individual, Maximum Contractual Term | 25 years | |||||||||||||||||
Payment of Royalties Equal to Percent of Gross Sales | 5.00% | |||||||||||||||||
Minimum Monthly Payment Amount to Offset Future Royalty Obligations | $ 2,500 | |||||||||||||||||
Revenue from Related Parties | $ 3,470 | $ 255 | ||||||||||||||||
Prepaid Royalties, Related Party, Noncurrent | 0 | $ 319,441 | ||||||||||||||||
Allowance for Doubtful Accounts Receivable, Ending Balance | 123,560 | |||||||||||||||||
Key Employee and Principal Stockholder and Current Director [Member] | Royalty Agreement Patent Defense [Member] | ||||||||||||||||||
Legal Fees | $ 203,208 |
Note 3 - Related Party Transa_4
Note 3 - Related Party Transactions - Notes Payable (Details) - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 |
Carrying value | $ 500,000 | $ 500,000 |
Related Party Note Payable Dated August 2017 [Member] | ||
Face value | 100,000 | |
Debt discount | 10,434 | |
Debt discount accretion | 3,131 | |
Carrying value | 92,695 | |
Related Party Note Payable Dated September 2017 [Member] | ||
Face value | 500,000 | |
Debt discount | 52,166 | |
Debt discount accretion | 15,148 | |
Carrying value | 462,982 | |
Related Party Note Payable Dated October 2017 [Member] | ||
Face value | 500,000 | |
Debt discount | 50,229 | |
Debt discount accretion | 10,665 | |
Carrying value | 460,436 | |
Related Party Note Payable Dated January 2018 [Member] | ||
Face value | 100,000 | |
Debt discount | 3,831 | |
Debt discount accretion | 3,831 | |
Carrying value | ||
Related Party Note Payable Dated January 2018 2 [Member] | ||
Face value | 500,000 | |
Debt discount | 50,590 | |
Debt discount accretion | 5,678 | |
Carrying value | 455,088 | |
Related Party Note Payable Dated March 2018 [Member] | ||
Face value | 200,000 | |
Debt discount | 20,281 | |
Debt discount accretion | 555 | |
Carrying value | 180,274 | |
Related Party Note Payable Dated March 2018 2 [Member] | ||
Face value | 200,000 | |
Debt discount | 20,279 | |
Debt discount accretion | 498 | |
Carrying value | 180,219 | |
Related Party Notes Payable [Member] | ||
Face value | 2,000,000 | |
Debt discount | 203,980 | |
Debt discount accretion | 35,674 | |
Carrying value | $ 1,831,694 |
Note 4 - Commitments (Details T
Note 4 - Commitments (Details Textual) - USD ($) | Feb. 20, 2018 | Jan. 31, 2016 | Mar. 31, 2018 | Mar. 31, 2017 | Sep. 01, 2016 |
Share Price | $ 3 | ||||
Research and Development Expense, Total | $ 84,817 | $ 76,381 | |||
SAA [Member] | |||||
Research and Development Expense, Total | 0 | 29,610 | |||
NASA ARC [Member] | SAA [Member] | |||||
Payments for Research Commitment | $ 373,750 | ||||
Contractual Agreement, Period | 5 years | ||||
BAM [Member] | |||||
License and Business Development Agreement, Consideration Received, to Purchase Shares in Connection to a Private Placement | $ 100,000 | ||||
BAM [Member] | Argo Space [Member] | |||||
License and Business Development Agreement, Contingent Consideration Arrangements, Range of Outcomes, Value, High | 900,000 | ||||
Lichtinger Goup [Member] | |||||
Maximum Amount of Capital Contributed | $ 500,000 | ||||
Argo Space [Member] | BAM [Member] | |||||
Equity Method Investment, Ownership Percentage | 20.00% | ||||
Capital Contribution Threshold | $ 500,000 | ||||
Warehouse in Okeechobee [Member] | |||||
Lessee, Operating Lease, Term of Contract | 2 years | ||||
Operating Leases, Future Minimum Payments Due, Next Twelve Months | $ 54,325 | $ 6,942 |
Note 5 - Note Payable (Details
Note 5 - Note Payable (Details Textual) - USD ($) | Jan. 18, 2018 | Dec. 14, 2017 | Dec. 31, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | Dec. 31, 2017 | Jan. 19, 2018 | Dec. 18, 2017 | Dec. 31, 2016 |
Proceeds from Notes Payable, Total | $ 100,000 | ||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 1.86 | $ 1.88 | $ 1.86 | $ 1.53 | |||||
Proceeds from Related Party Debt | $ 1,000,000 | ||||||||
Accretion Expense | 23,642 | ||||||||
Warrants Issued in Connection with Unsecured Promissory Note [Member] | |||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 10,000 | 50,000 | |||||||
Warrants and Rights Outstanding, Term | 5 years | 5 years | |||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 3 | $ 3 | |||||||
Unsecured Promissory Note [Member] | |||||||||
Debt Instrument, Face Amount | $ 200,000 | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||||||||
Proceeds from Notes Payable, Total | $ 200,000 | ||||||||
Debt Instrument, Unamortized Discount, Total | 18,652 | $ 18,652 | |||||||
Debt Instrument, Maturity Date | Dec. 13, 2019 | ||||||||
Unsecured Promissory Note [Member] | Other Expense [Member] | |||||||||
Amortization of Debt Discount (Premium) | 2,300 | ||||||||
Unsecured Promissory Note 2 [Member] | |||||||||
Debt Instrument, Face Amount | $ 100,000 | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||||||||
Debt Instrument, Unamortized Discount, Total | $ 7,124 | ||||||||
Proceeds from Related Party Debt | $ 100,000 | ||||||||
Debt Instrument, Maturity Date | Jan. 18, 2020 | ||||||||
Unsecured Promissory Note 2 [Member] | Other Expense [Member] | |||||||||
Accretion Expense | 703 | ||||||||
Notes Payable, Other Payables [Member] | |||||||||
Debt Instrument, Face Amount | $ 223,707 | $ 223,707 | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 7.50% | 7.50% | |||||||
Debt Instrument, Periodic Payment, Total | $ 19,353 | ||||||||
Notes Payable, Total | $ 154,822 |
Note 5 - Note Payable - Notes P
Note 5 - Note Payable - Notes Payable (Details) - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 |
Carrying value | $ 277,660 | $ 181,782 |
Unsecured Promissory Note Payable Dated December 2017 [Member] | ||
Face value | 200,000 | |
Debt discount | 18,652 | |
Debt discount accretion | 2,733 | |
Carrying value | 184,081 | |
Unsecured Promissory Note Payable Dated January 2018 3 [Member] | ||
Face value | 100,000 | |
Debt discount | 7,124 | |
Debt discount accretion | 703 | |
Carrying value | 93,579 | |
Unsecured Promissory Note [Member] | ||
Face value | 300,000 | |
Debt discount | 25,776 | |
Debt discount accretion | 3,436 | |
Carrying value | $ 277,660 |
Note 6 - Equity (Details Textua
Note 6 - Equity (Details Textual) | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||||||
Jan. 31, 2018USD ($)$ / sharesshares | Mar. 31, 2018USD ($)$ / sharesshares | Mar. 31, 2017USD ($) | Dec. 31, 2017USD ($)$ / sharesshares | Dec. 31, 2016USD ($)$ / shares | Mar. 12, 2018$ / sharesshares | Mar. 09, 2018$ / sharesshares | Mar. 08, 2018USD ($)$ / shares | Feb. 20, 2018$ / shares | Jan. 19, 2018$ / sharesshares | Jan. 18, 2018USD ($) | Dec. 18, 2017$ / sharesshares | Dec. 14, 2017USD ($) | Oct. 31, 2017USD ($)$ / sharesshares | Sep. 30, 2017$ / sharesshares | Nov. 30, 2015shares | |
Payments of Stock Issuance Costs | $ 1,680 | $ 53,400 | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.88 | $ 1.86 | $ 1.53 | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 25,000 | 440,000 | ||||||||||||||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares | $ 3 | $ 3 | ||||||||||||||
Share Price | $ / shares | $ 3 | |||||||||||||||
Equity Incentive Plan 2015 [Member] | ||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 4,000,000 | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 25,000 | |||||||||||||||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares | $ 1.25 | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | $ 19,208 | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | 0.00% | 0.00% | ||||||||||||||
Share Price | $ / shares | $ 1.21 | |||||||||||||||
Equity Incentive Plan 2015 [Member] | Employee Stock Option [Member] | ||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | $ 0 | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 101.70% | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 2.58% | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | 5 years | |||||||||||||||
Director [Member] | ||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 50,000 | |||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | |||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | |||||||||||||||
Unsecured Promissory Note 2 [Member] | ||||||||||||||||
Debt Instrument, Face Amount | $ 100,000 | |||||||||||||||
Debt Instrument, Unamortized Discount, Total | $ 7,124 | |||||||||||||||
Unsecured Promissory Note [Member] | ||||||||||||||||
Debt Instrument, Face Amount | $ 200,000 | |||||||||||||||
Debt Instrument, Unamortized Discount, Total | $ 18,652 | |||||||||||||||
Unsecured Promissory Note [Member] | In-house Council [Member] | ||||||||||||||||
Proceeds from Issuance of Long-term Debt, Total | $ 100,000 | |||||||||||||||
Unsecured Promissory Note [Member] | Rio Vista [Member] | ||||||||||||||||
Debt Instrument, Face Amount | 500,000 | |||||||||||||||
Debt Instrument, Unamortized Discount, Total | $ 35,590 | $ 50,229 | ||||||||||||||
Unsecured Promissory Note [Member] | Director [Member] | Third Note [Member] | ||||||||||||||||
Debt Instrument, Face Amount | $ 200,000 | |||||||||||||||
Debt Instrument, Unamortized Discount, Total | 14,281 | $ 14,281 | ||||||||||||||
Unsecured Promissory Note [Member] | BPI [Member] | Fourth Note [Member] | ||||||||||||||||
Debt Instrument, Face Amount | 200,000 | |||||||||||||||
Debt Instrument, Unamortized Discount, Total | $ 14,279 | |||||||||||||||
New Smith Warrant [Member] | Measurement Input, Expected Term [Member] | ||||||||||||||||
Warrants and Rights Outstanding, Measurement Input | 0.05 | |||||||||||||||
Warrants Issued for Services [Member] | ||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 75,000 | |||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | |||||||||||||||
Warrants and Rights Outstanding | $ 57,570 | |||||||||||||||
Warrants Issued in Connection with Unsecured Promissory Note [Member] | ||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 10,000 | 50,000 | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | $ 3 | ||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | 5 years | ||||||||||||||
Warrants Issued in Connection with Unsecured Promissory Note [Member] | In-house Council [Member] | ||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 5,000 | |||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | |||||||||||||||
Warrants and Rights Outstanding | $ 3,831 | |||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | |||||||||||||||
Warrants Issued to Rio Vista [Member] | Rio Vista [Member] | ||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 50,000 | 50,000 | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | $ 3 | ||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | 5 years | ||||||||||||||
Third Warrant [Member] | Director [Member] | ||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 20,000 | 20,000 | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | $ 3 | $ 3 | |||||||||||||
Warrants and Rights Outstanding, Term | 5 years | 5 years | 5 years | |||||||||||||
Fourth Warrant [Member] | BPI [Member] | ||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 20,000 | 20,000 | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | $ 3 | ||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | 5 years | ||||||||||||||
Private Placement [Member] | ||||||||||||||||
Stock Issued During Period, Value, New Issues | $ 10,000,000 | |||||||||||||||
Shares Issued, Price Per Share | $ / shares | $ 3 | |||||||||||||||
Stock Issued During Period, Shares, New Issues | shares | 55,334 | |||||||||||||||
Proceeds from Issuance of Private Placement | $ 166,002 | |||||||||||||||
Payments of Stock Issuance Costs | $ 1,680 | |||||||||||||||
Private Placement [Member] | Fully Vested, Non-forfeitable Warrants [Member] | ||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 490 | |||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | |||||||||||||||
Adjustments to Additional Paid in Capital, Warrant Issued | $ 377 |
Note 6 - Equity - Warrant Activ
Note 6 - Equity - Warrant Activity (Details) - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2018 | Dec. 31, 2017 | |
Outstanding, number of warrants (in shares) | 10,713,175 | 9,664,733 |
Outstanding, weighted average exercise price (in dollars per share) | $ 1.86 | $ 1.53 |
Granted, number of warrants (in shares) | 180,490 | 1,838,442 |
Granted, weighted average exercise price (in dollars per share) | $ 3 | $ 2.01 |
Exercised, number of warrants (in shares) | (790,000) | |
Exercised, weighted average exercise price (in dollars per share) | $ 2 | |
Cancelled/Forfeited (in shares) | ||
Outstanding and exercisable, weighted average remaining contractual life (Year) | 2 years 219 days | 2 years 292 days |
Outstanding and exercisable, aggregate intrinsic value | $ 2,861,010 | $ 2,606,698 |
Outstanding, number of warrants (in shares) | 10,893,665 | 10,713,175 |
Outstanding, weighted average exercise price (in dollars per share) | $ 1.88 | $ 1.86 |
Note 6 - Equity - Option Activi
Note 6 - Equity - Option Activity (Details) - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2018 | Dec. 31, 2017 | |
Outstanding, number of options (in shares) | 3,165,000 | 2,755,000 |
Outstanding, weighted average exercise price (in dollars per share) | $ 1.49 | $ 1.25 |
Granted, number of options (in shares) | 25,000 | 440,000 |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 3 | $ 3 |
Exercised, number of options (in shares) | ||
Exercised, weighted average exercise price (in dollars per share) | ||
Cancelled/Forfeited, number of options (in shares) | (700,000) | (30,000) |
Cancelled/Forfeited, weighted average exercise price (in dollars per share) | $ (1.25) | $ (1.25) |
Outstanding, number of options (in shares) | 2,490,000 | 3,165,000 |
Outstanding, weighted average exercise price (in dollars per share) | $ 1.58 | $ 1.49 |
Outstanding, weighted average remaining contractual life (Year) | 8 years 146 days | 8 years 182 days |
Outstanding, aggregate intrinsic value | $ 192,850 | |
Exercisable, number of options (in shares) | 2,072,500 | 2,750,000 |
Exercisable, weighted average exercise price (in dollars per share) | $ 1.33 | $ 1.27 |
Exercisable, weighted average remaining contractual life (Year) | 8 years 73 days | 8 years 73 days |
Exercisable, aggregate intrinsic value | $ 192,850 |
Note 7 - Subsequent Events (Det
Note 7 - Subsequent Events (Details Textual) - USD ($) | Jul. 17, 2018 | Jul. 02, 2018 | Jun. 29, 2018 | May 02, 2018 | Apr. 24, 2018 | Mar. 31, 2018 | Mar. 31, 2017 | Oct. 28, 2018 | Oct. 22, 2018 | Mar. 12, 2018 | Dec. 31, 2017 | Dec. 14, 2017 | Sep. 30, 2017 | Dec. 31, 2016 | Oct. 31, 2016 |
Proceeds from Related Party Debt | $ 1,000,000 | ||||||||||||||
Repayments of Related Party Debt | 100,000 | ||||||||||||||
Proceeds from Issuance of Common Stock | 166,002 | 688,500 | |||||||||||||
Payments of Stock Issuance Costs | $ 1,680 | $ 53,400 | |||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 1.88 | $ 1.86 | $ 1.53 | ||||||||||||
2016 Private Offering [Member] | |||||||||||||||
Private Offering, Number of Shares Authorized | 10,000,000 | ||||||||||||||
2016 Private Offering [Member] | Common Stock [Member] | |||||||||||||||
Private Offering, Number of Shares Authorized | 3,333,333 | ||||||||||||||
Shares Issued, Price Per Share | $ 3 | ||||||||||||||
Subsequent Event [Member] | |||||||||||||||
Proceeds from Issuance of Common Stock | $ 745,000 | ||||||||||||||
Subsequent Event [Member] | 2016 Private Offering [Member] | |||||||||||||||
Stock Issued During Period, Value, New Issues | $ 248,384 | ||||||||||||||
Proceeds from Issuance of Common Stock | 745,151 | ||||||||||||||
Payments of Stock Issuance Costs | $ 24,000 | ||||||||||||||
Subsequent Event [Member] | Warrants Issued with 2016 Private Offering [Member] | |||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 7,000 | ||||||||||||||
Subsequent Event [Member] | June 2018 Offering Warrants [Member] | |||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 2,000,000 | ||||||||||||||
Warrants and Rights Outstanding, Term | 2 years | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 1 | ||||||||||||||
Subsequent Event [Member] | Warrants Issued in Connection with Issuance of Secured Notes to Shareholders [Member] | |||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 2,050,000 | ||||||||||||||
Subsequent Event [Member] | Fully Vested, Non-forfeitable Warrants [Member] | |||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 165,000 | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 3 | ||||||||||||||
Director [Member] | |||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 50,000 | ||||||||||||||
Warrants and Rights Outstanding, Term | 5 years | ||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 3 | ||||||||||||||
Director [Member] | Subsequent Event [Member] | June 2018 Offering [Member] | |||||||||||||||
Proceeds from Issuance of Private Placement | $ 250,000 | $ 250,000 | $ 1,000,000 | ||||||||||||
Director [Member] | Subsequent Event [Member] | Fifth Warrant [Member] | |||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 30,000 | ||||||||||||||
Shareholders [Member] | Subsequent Event [Member] | June 2018 Offering [Member] | |||||||||||||||
Proceeds from Issuance of Private Placement | $ 550,000 | ||||||||||||||
June 2018 Offering Notes [Member] | Subsequent Event [Member] | |||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||||||||||||||
Secured Convertible Promissory Notes, Issuable, Maximum Amount | $ 2,000,000 | ||||||||||||||
Debt Instrument, Face Amount | $ 2,050,000 | ||||||||||||||
Unsecured Promissory Note [Member] | |||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||||||||||||||
Debt Instrument, Face Amount | $ 200,000 | ||||||||||||||
Unsecured Promissory Note [Member] | Fifth Note [Member] | Director [Member] | Subsequent Event [Member] | |||||||||||||||
Proceeds from Related Party Debt | $ 300,001 | ||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||||||||||||||
Unsecured Promissory Note [Member] | Fourth Note [Member] | BPI [Member] | |||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||||||||||||||
Debt Instrument, Face Amount | $ 200,000 | ||||||||||||||
Unsecured Promissory Note [Member] | Fourth Note [Member] | BPI [Member] | Subsequent Event [Member] | |||||||||||||||
Repayments of Related Party Debt | $ 200,000 |